Manager TitleAgeSince
Chief Executive Officer 72 29/06/2022
Director of Finance/CFO 62 25/07/2022
Chief Operating Officer 78 31/12/2019
Director TitleAgeSince
Director/Board Member 72 29/06/2022
Date Insider Type Main position Quantity % Market Cap.
30/06/22 Other

Chief Executive Officer

80,729,883 1,566.5178%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+9,900.00% - - 11.2K
-3.00%+0.33%+77.39%+109.41% 73.96B
+1.90%+23.53%+56.60%+97.76% 64.66B
+1.00%+2.19%-4.64%+474.77% 27.32B
+3.18%+23.05%+3.41%-2.54% 27.86B
+2.74%+11.55%+66.56%+27.34% 25.97B
+0.47%+6.12%+36.66%-13.79% 19.98B
+1.82%-3.11%+245.72%+423.83% 17.84B
+0.94%+2.38%+24.83%+552.12% 16.24B
+0.77%+5.49%+39.64%+152.95% 13.3B
Average +0.98%+6.16%+60.68%+202.43% 31.9B
Weighted average by Cap. +0.54%+6.66%+59.65%+161.29%
Logo Manuka, Inc.
Manuka, Inc., formerly Artemis Therapeutics, Inc., is focused on offering facial skincare products based on Manuka honey and bee venom. The Company’s products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. It regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.
Employees
-
  1. Stock Market
  2. Stocks
  3. ATMS Stock